- Review
PARP Inhibitors and Proteins Interacting with SLX4
- Lars Petter Jordheim
PARP inhibitors are small molecules currently used with success in the treatment of certain cancer patients. Their action was first shown to be specific to cells with DNA repair deficiencies, such as BRCA-mutant cancers. However, recent work has sugg...

